Skip to contentA
Axim Biotechnologies, Inc.
A
AXIMAxim Biotechnologies, Inc. Q1 2015 · 10-Q
Revenue$0.00$0.00−100.0% vs Q1 2014 Net Income-$506.95K-$506.95KN/M vs Q1 2014 EPS Diluted-$0.02-$0.02— vs Q1 2014 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR
-$488,818
—
Operating Cash Flow-$465,874N/M ended Mar 31, 2015 · filed May 13, 2015 · 43 d after period end